TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update

Go back to TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update

TG Therapeutics, Inc. (TGTX) Posts Q4 Loss of 19c/Share

March 5, 2014 4:12 PM EST

TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q4 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $40 million.

For earnings history and earnings-related data on TG Therapeutics, Inc. (TGTX) click here.... More